About
Alex Blyth is a biotech entrepreneur who founded LIfT BioSciences in 2016, where the current company site lists him as Founder & Observer. He also runs The Mission Fund as Managing Partner, positioning it to finance early proof-of-concept work in biotech, especially solid tumours, CNS indications, and longevity-related conditions. His public profile is strongest as a biotech founder and emerging fund operator rather than a documented personal capital owner.
Areas of interest
biotechoncologycell therapylongevityageing-related conditionsmental healthCNS therapeuticsproof-of-concept biotech financing